Calorie Restriction With or Without Metformin in Triple Negative Breast Cancer

clinical trial

Details

Instance of: clinical trial
Start time: 1 March 2020
End time: 31 December 2022
Main subject: metformin
clinical trial phase: phase II clinical trial
maximum age: 75
minimum age: 18
number of participants: 90
research intervention: (RS)-cyclophosphamide, doxorubicin, Caelyx, metformin, paclitaxel
short name: BREAKFAST
study type: interventional study
title: Targeting Triple Negative BREAst Cancer Metabolism With a Combination of Chemotherapy and a Diet Mimicking FASTing Plus/Minus Metformin in the Preoperative Setting: the BREAKFAST Trial

Nothing in the MetaHistoryBook collection references this item yet.